1. Home
  2. AIFU vs RLYB Comparison

AIFU vs RLYB Comparison

Compare AIFU & RLYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AIFU
  • RLYB
  • Stock Information
  • Founded
  • AIFU 1998
  • RLYB 2018
  • Country
  • AIFU China
  • RLYB United States
  • Employees
  • AIFU N/A
  • RLYB N/A
  • Industry
  • AIFU
  • RLYB Biotechnology: Pharmaceutical Preparations
  • Sector
  • AIFU
  • RLYB Health Care
  • Exchange
  • AIFU NYSE
  • RLYB Nasdaq
  • Market Cap
  • AIFU 12.2M
  • RLYB 14.4M
  • IPO Year
  • AIFU 2007
  • RLYB 2021
  • Fundamental
  • Price
  • AIFU $5.00
  • RLYB $0.35
  • Analyst Decision
  • AIFU
  • RLYB Hold
  • Analyst Count
  • AIFU 0
  • RLYB 3
  • Target Price
  • AIFU N/A
  • RLYB $15.00
  • AVG Volume (30 Days)
  • AIFU 192.5K
  • RLYB 323.9K
  • Earning Date
  • AIFU 07-07-2025
  • RLYB 08-07-2025
  • Dividend Yield
  • AIFU N/A
  • RLYB N/A
  • EPS Growth
  • AIFU 61.54
  • RLYB N/A
  • EPS
  • AIFU 23.02
  • RLYB N/A
  • Revenue
  • AIFU $247,815,758.00
  • RLYB $848,000.00
  • Revenue This Year
  • AIFU N/A
  • RLYB N/A
  • Revenue Next Year
  • AIFU N/A
  • RLYB N/A
  • P/E Ratio
  • AIFU $0.17
  • RLYB N/A
  • Revenue Growth
  • AIFU N/A
  • RLYB N/A
  • 52 Week Low
  • AIFU $1.50
  • RLYB $0.22
  • 52 Week High
  • AIFU $7.59
  • RLYB $1.54
  • Technical
  • Relative Strength Index (RSI)
  • AIFU N/A
  • RLYB 53.64
  • Support Level
  • AIFU N/A
  • RLYB $0.30
  • Resistance Level
  • AIFU N/A
  • RLYB $0.38
  • Average True Range (ATR)
  • AIFU 0.00
  • RLYB 0.04
  • MACD
  • AIFU 0.00
  • RLYB 0.00
  • Stochastic Oscillator
  • AIFU 0.00
  • RLYB 49.29

About AIFU FANHUA INC SPON ADS EACH REPR 20 ORD SHS

AIFU Inc is an independent financial services provider in China. It offer end-to-end business solutions spanning compliance, technology, products, services, capital flow and professional training. It connects customers with insurance protection, retirement planning, health management, asset management, and family governance services. The company operated in two segments: the insurance agency segment, which derives maximum revenue, consists of providing agency services for distributing life insurance products and non-life insurance products on behalf of insurance companies, and the claims adjusting segment consisting of providing pre-underwriting survey services, claims adjusting services, disposal of residual value services, loading/unloading supervision services and consulting services.

About RLYB Rallybio Corporation

Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.

Share on Social Networks: